P659-2039 Screening compound: 4-methyl-1-{5-methyl-2-[(3-methylpiperidin-1-yl)methyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine

P659-2039 Screening compound: 4-methyl-1-{5-methyl-2-[(3-methylpiperidin-1-yl)methyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine
P659-2039 Screening compound: 4-methyl-1-{5-methyl-2-[(3-methylpiperidin-1-yl)methyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound P659-2039
4-methyl-1-{5-methyl-2-[(3-methylpiperidin-1-yl)methyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P659-2039

Molecular Formula

C19H30N6 (C19 H30 N6)

Compound Name

4-methyl-1-{5-methyl-2-[(3-methylpiperidin-1-yl)methyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine

IUPAC name

4-methyl-1-{5-methyl-2-[(3-methylpiperidin-1-yl)methyl]-[124]triazolo[15-a]pyrimidin-7-yl}piperidine

SMILES

CC(CC1)CCN1c1cc(C)nc2nc(CN3CC(C)CCC3)nn12

InChI

InChI=1S/C19H30N6/c1-14-6-9-24(10-7-14)18-11-16(3)20-19-21-17(22-25(18)19)13-23-8-4-5-15(2)12-23/h11,14-15H,4-10,12-13H2,1-3H3/t15-/m0/s1

InChI Key

IKIJPDJVSCIOGM-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD27609862

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

342.49

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.052

Distribution Coefficient, logD

2.402

Water Solubility, LogSw

-3.03

Polar Surface Area

38.045

Acid Dissociation Constant (pKa)

24.11

Base Dissociation Constant (pKb)

7.94

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

73.70

P659-2039 in Drug Discovery

Included in Screening Libraries

CNS BBB Library (22607 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with P659-2039 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P659-2039?
Check Price and Availability of P659-2039, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P659-2039 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P659-2039
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P659-2039
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P659-2039 available by request